Related Experiment Video
Updated: May 6, 2026

04:48
Application of Deep Learning-Based Medical Image Segmentation via Orbital Computed Tomography
Published on: November 30, 2022
3.6K
An Ensemble Learning Artificial Intelligence Model for Alzheimer's Disease Detection Using OCT
An Ran Ran1,2, Xiaoyan Hu1, Herbert Y H Hui1
1Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong SAR, China.
Ophthalmology Science
|February 20, 2026
Summary
This study developed a deep learning model using retinal OCT scans to detect Alzheimer's disease (AD) dementia and early AD. The model shows promise for opportunistic AD screening during eye exams.
Area of Science:
- Ophthalmology
- Neurology
- Artificial Intelligence
Background:
- Alzheimer's disease (AD) diagnosis relies on clinical assessment and costly biomarkers.
- Retinal imaging offers a non-invasive window into neurodegenerative changes associated with AD.
- Deep learning (DL) models show potential for analyzing complex imaging data.
Purpose of the Study:
- To develop and validate an ensemble DL model using Optical Coherence Tomography (OCT) for detecting AD-dementia and early AD.
- To integrate multiple OCT-derived inputs for enhanced diagnostic performance.
- To assess the model's ability to classify mild cognitive impairment (MCI) and AD with PET-confirmed biomarkers.
Main Methods:
- A retrospective case-control study involving participants with AD-dementia, MCI, and cognitively normal controls.
- Development of two base DL models (ONH and macula) using various OCT imaging data.
- An ensemble model was created by integrating the base models for unified classification.
- External validation was performed using independent cohorts with PET-confirmed amyloid-beta status.
Main Results:
- The ensemble model achieved an Area Under the Receiver Operating Characteristic Curve (AUROC) of 0.943 for detecting AD-dementia in internal validation.
- For external validation, the model showed AUROCs of 0.786 and 0.795 for AD-dementia detection.
- The model achieved AUROCs around 0.79 for detecting AD-MCI (PET-based) in external cohorts.
Conclusions:
- The proposed ensemble DL model effectively detects AD-dementia and early AD using OCT imaging.
- Integrating multiple DL models and OCT inputs enhances diagnostic accuracy.
- This approach enables opportunistic AD screening during routine ophthalmic examinations.
Related Concept Videos
Alzheimer's Disease: Overview
1.7K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
Alzheimer's Disease: Treatment
1.3K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.3K
Alzheimer Disease l: Introduction
21
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
21
Alzheimer Disease ll: Pathophysiology
35
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
35

